Custom Control Development
Various
Development/CommercialActive
Key Facts
About Anchor Molecular
Founded in 2016 and headquartered in San Diego, Anchor Molecular operates as a critical supplier in the molecular diagnostics value chain, providing synthetic and biological reference standards. The company serves a growing market driven by the need for assay validation, regulatory compliance, and reliable performance monitoring in clinical labs. Its business model is based on selling standardized and custom QC materials, positioning it as a revenue-generating services and diagnostics tools company. Anchor Molecular's success hinges on its technical expertise in engineering complex molecular controls and its ability to form collaborative partnerships with diagnostic developers.
View full company profileTherapeutic Areas
Other Various Drugs
| Drug | Company | Phase |
|---|---|---|
| New Generic Approvals | China SXT Pharmaceuticals | Application Submitted / BE Stage |
| New Dosage Form Development | Universe Pharmaceuticals | Development |
| New TCM Formula Registration | Universe Pharmaceuticals | Development |
| Bag APIs | ChemWerth | Approved |
| Oral APIs | ChemWerth | Approved |
| Companion Diagnostics Development | Kiffik Biomedical | Pre-clinical |
| Portfolio of Complex Generics & 505(b)(2) Products | Alvogen | Approved/Commercial |
| Portfolio of 40+ products | Praxgen Pharmaceuticals | Development |
| Portfolio from Steriscience Partnership | Armas Pharmaceuticals | ANDA Development/Filing |
| Generic Medicinal Products Development | Basic Pharma | Commercial |
| Platform Expansion - Other Specialty Molecules | River Stone Biotech | Development |
| Information not publicly detailed | Elpen Pharmaceutical | Not Disclosed |